Dr. Leah Johnson and Dr. Cary Herzberg react to new research where indigo light prevented myopia in tree shrews, and explain why they still tell parents to send kids outside.

After ten years building Treehouse Eyes, Matt Oerding says the practices that succeed at myopia management aren't the ones with the best story. They're the ones with a system, a doctor with conviction.

Why a lens-design software company opened its own lab, and how they get new fitters to a first-fit win.

If there’s ever a Mount Rushmore of myopia management, Dr. Thomas Aller is on it. His work shaped where this field is today, and most are using a version of it every week, whether we know it or not. So I wanted to hear how it actually started. The answer: frustration, a payphone, and a lot of stubbornness.

Dr. Cary Herzberg and Dr. Andrew Brauer on skipping the profession and taking myopia management straight to parents.

Dr. Matthew Martin on front-loading the hard part of ortho-K so the next ten years mostly run themselves, and why doctors who keep redesigning happy patients are making their own work.

Dr. Shefali Miglani is one of the most successful myopia doctors I know, and she opened our conversation by telling me she failed. She presented the lens, the tech and the topography map, and parents walked out without signing up.

AI that predicts ten years of eye growth from one retinal photo. Our panel on Dr. David Ng's report from Vision China 2026 — and what it says about how far behind we are.

This is one of three stories from this month's Myopia News Monthly, alongside a study on late-onset myopia in high schoolers and a new RCT on red light therapy.

Full episode: myopiamindset.substack.com

Dr. Jennifer Lyerly walks through the STAR study numbers, the parents who just want the glasses, and the 25-year-old nobody knows what to do with.

Dr. Carrie Hartigan on building a pediatric-only practice, training a myopia coordinator, winning pediatrician referrals, and why one flat fee changed how she treats every kid.

Dr. David Ng was a happy general practice OD in 2002. Then he put a retinoscope in front of his three-year-old son.

The AMA takes a stand on myopia. When does the back optic zone actually matter? Sydnexis gets a second shot.

Dr. Cary Herzberg on why the surprise rejection stung, what the advisory committee will weigh, and why an approved drop changes everything for preventive eye care.

He inherited a handful of poorly-fit ortho-K patients, gave himself six months to master the specialty, and ended up co-founding a lens design company. Dr. Sukh Gill returns for a deep-dive interview.

Here’s a question Dr. Cary Herzberg wants every optometrist to ask in the mirror: if you dropped every vision care plan tomorrow, could your practice survive?

The "high myopia as disease" debate, atropine + ortho-k combo therapy, and axial length as standard of care.

For all the noise around artificial intelligence, the most useful question for a myopia practice isn’t “Will this replace me?” It’s “Can this help me do the work I already know I should be doing?”

HHS and the Surgeon General issue a warning on children’s screen use. The FDA rejects Sydnexis’ SYD-101 — despite the STAR trial meeting its primary endpoint. Hoya’s MiYOSMART iQ posts some of the strongest myopia control data ever reported.

Dr. Cary Herzberg — 40+ years in specialty optometry — on the insurance model burning doctors out, the specialty care exit ramp, and whether the profession can save itself.

Dr. Marie Homa-Palladino on Listening, Connection, and Myopia Management Done Right